PPARgamma agonist 14 (compound 3) is a PPARy agonist (EC50=2.4 µM) with anti-diabetic activity. PPARgamma agonist 14 can improve intracellular glucose uptake, promote insulin release, and lower blood sugar. In addition, PPARgamma agonist 14 also improves mitochondrial function, reduces oxidative stress, and inhibits inflammatory factors. PPARgamma agonist 14 can be used in the study of neurodegenerative diseases, neuroinflammatory diseases, and other diseases[1].
Molekulargewicht:
316.31
Reinheit:
98
CAS Nummer:
[6951-57-1]
Formel:
C17H16O6
Target-Kategorie:
PPAR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
